PTC Therapeutics Stock Price (NASDAQ:PTCT)

Add to My Stocks
$14.71 $0.76 (4.91%) PTCT stock closing price Jan 17, 2017 (Closing)
YOUR DAILY UPDATE ON
PTCT
PTC Therapeutics
17 JAN 2017
amigobulls logo
PTCT hand_up
PTCT vs S&P 500
Closing Price: Jan 17, 2017
PTCT
$14.71 ( -4.91%)
S&P 500
2267.9 ( -0.3%)
PTCT
52 Week Price Range
1 Year Return: -33.06%
Q3 Growth*
Excellent
Profitable ?
No
net image
2016 Q3 Net Loss
-236.7%
home image
Rating
PTCT POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

PTC Therapeutics Snapshot Video

13 6 2

PTCT Stock Details

Prev Close* : $15.47
Market Cap:
$530.9M
Day Low: $14.36
52 Week Low: $4.03
Open: $15.38
Volume: 1068535
Day High: $15.38
52 Week High: $30.23
Dividend:
N/A

Latest Stock Market News

Latest Articles

PTC Therapeutics News - From Partners

PTCT Stockcharts

View PTCT PE ratio, PS ratio stocks charts and compare with peers.
PTCT Chart
Note: Compare PTC Therapeutics stock price history with the index and industry peers.

PTC Therapeutics Valuation

PS ratio (
price to sales ratio
)
7.14
PB ratio (
price to book ratio
)
2.52

PTC Therapeutics Financial Ratios

Asset Turnover
0.31
Receivables Turnover
3.95
Debt to Equity
0.69

PTCT Industry Peers

Company Price Change (%)
Sciclone Pharma (SCLN)10.40.15 (1.42%)
Cynapsus Therapeutics (CYNA)40.480 (0%)
Catabasis Pharma (CATB)4.290 (0%)
Sarepta Therapeutics (SRPT)36.131.7 (4.49%)
Prosensa Holding (RNA)18.650 (0%)
Avexis (AVXS)52.510.1 (0.19%)
Vertex Pharma (VRTX)81.551.62 (1.95%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ImmunoGen (IMGN)2.560.13 (5.35%)
USANA Health Sciences (USNA)61.850.15 (0.24%)
Taro Pharma (TARO)104.920.07 (0.07%)
Top gainers from Medical-Drugs industry
* As of Jan 18, 2017
CompanyPriceChange (%)
Concert Pharma (CNCE)9.011.46 (13.94%)
Xencor (XNCR)23.312.85 (10.89%)
Egalet (EGLT)5.340.56 (9.49%)
Rigel Pharma (RIGL)2.340.17 (6.77%)
Zogenix (ZGNX)9.650.7 (6.76%)
La Jolla Pharma (LJPC)20.421.47 (6.72%)
Esperion Therapeutics (ESPR)11.20.8 (6.67%)
Top losers from Medical-Drugs industry
* As of Jan 18, 2017

PTC Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues36.76M25.24M34.69M33.94M105.41M
Net Income-170.44M-93.75M-51.57M-26.23M30.9M
Total Operating Expense203.89M124.65M80.08M60.74M74.82M
view PTC Therapeutics, Inc. income statement
balance sheet20152014201320122011
Total Assets368.04M333.21M151.9M13.07M44.14M
Total Liabilities142.04M34.75M15.36M31.88M68.37M
Shareholders Equity226M298.46M136.54M-18.81M-24.22M
view PTC Therapeutics, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities4.69M13.19M-12.31M-25.12M-57.31M
Net Cash From (Used By) Operating Activities-124.33M-57.27M-46.92M-47.92M-20.76M
Increase (Decrease) In Prop Plant And Equipment-2.72M-4.66M-0.84M-0.18M-0.16M
view PTC Therapeutics, Inc. cashflow statement

PTC Therapeutics, Inc. Stock News - Partner Headlines

PTC Therapeutics Stock Message Board

An investor needs to spend 14.71 to buy PTCT stock, as the closing PTC Therapeutics stock price is 14.71. Looking at PTC Therapeutics market capitalization, which currently stands at 530.9M, we can say that PTCT stock is a Small cap stock. PTC Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that PTC Therapeutics is worth a lot, it will most likely be reflected in an inflated PTC Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1068535 shares were traded with a closing stock price of 14.71 as of 17 Jan, 2017, as can be seen from PTC Therapeutics stock quote. One can view PTC Therapeutics stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. PTC Therapeutics does not pay dividends. PTC Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.